Published in Proc Natl Acad Sci U S A on December 12, 2006
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol (2008) 6.82
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol (2009) 5.65
The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci (2013) 3.16
Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci (2007) 3.02
Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci U S A (2008) 2.31
Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab (2012) 1.92
Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc Natl Acad Sci U S A (2008) 1.84
Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet (2010) 1.70
Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol Ther (2008) 1.57
Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One (2009) 1.45
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 1.40
Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse. Hum Mol Genet (2009) 1.35
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci U S A (2009) 1.33
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum Mol Genet (2008) 1.32
Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron (2014) 1.32
Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis. J Biol Chem (2009) 1.30
Role of TGF-β signaling in inherited and acquired myopathies. Skelet Muscle (2011) 1.28
SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Mamm Genome (2011) 1.17
Glial cells in amyotrophic lateral sclerosis. Exp Neurol (2014) 1.11
Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J Cell Biol (2012) 1.10
Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res (2007) 1.09
Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice. Hum Mol Genet (2009) 1.09
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2014) 1.08
Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol (2011) 1.07
Neuroprotection by gene therapy targeting mutant SOD1 in individual pools of motor neurons does not translate into therapeutic benefit in fALS mice. Mol Ther (2010) 1.07
The complex molecular biology of amyotrophic lateral sclerosis (ALS). Prog Mol Biol Transl Sci (2012) 1.05
Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype. Hum Mol Genet (2011) 1.03
Combination of myostatin pathway interference and dystrophin rescue enhances tetanic and specific force in dystrophic mdx mice. Mol Ther (2010) 1.01
Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp Neurol (2007) 1.00
Motor neuron trophic factors: therapeutic use in ALS? Brain Res Rev (2010) 0.98
Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. J Neurosci (2014) 0.95
Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS One (2013) 0.94
Motor neuron-immune interactions: the vicious circle of ALS. J Neural Transm (Vienna) (2010) 0.93
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models. Dis Model Mech (2012) 0.92
Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods. Brain Behav (2013) 0.91
Differential autophagy power in the spinal cord and muscle of transgenic ALS mice. Front Cell Neurosci (2013) 0.89
State of the art and the dark side of amyotrophic lateral sclerosis. World J Biol Chem (2010) 0.89
Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments. Curr Drug Targets (2010) 0.89
Neuroinflammation in motor neuron disease. Nagoya J Med Sci (2015) 0.89
Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice. PLoS One (2010) 0.88
Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality? J Anat (2011) 0.87
Genetic rodent models of amyotrophic lateral sclerosis. J Biomed Biotechnol (2011) 0.87
Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Biochim Biophys Acta (2008) 0.86
A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients. PLoS One (2016) 0.82
Absence of Nrf2 or its selective overexpression in neurons and muscle does not affect survival in ALS-linked mutant hSOD1 mouse models. PLoS One (2013) 0.80
Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Exp Neurol (2015) 0.79
A perspective on stem cell modeling of amyotrophic lateral sclerosis. Cell Cycle (2015) 0.79
Smads as muscle biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol (2014) 0.78
Therapy development for spinal muscular atrophy in SMN independent targets. Neural Plast (2012) 0.78
The anabolic/androgenic steroid nandrolone exacerbates gene expression modifications induced by mutant SOD1 in muscles of mice models of amyotrophic lateral sclerosis. Pharmacol Res (2011) 0.78
Postnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse model. Nat Commun (2013) 0.78
Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases. Stem Cell Res (2016) 0.78
SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of whole-body changes in metabolism. Neurodegener Dis (2013) 0.77
Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass. JCI Insight (2016) 0.76
Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy. Sci Rep (2015) 0.76
Motor neuron degeneration in spinal and Bulbar Muscular Atrophy is a skeletal muscle-driven process: Relevance to therapy development and implications for related motor neuron diseases. Rare Dis (2014) 0.75
New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. J Physiol (2016) 0.75
Adducin at the Neuromuscular Junction in Amyotrophic Lateral Sclerosis: Hanging on for Dear Life. Front Cell Neurosci (2016) 0.75
Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis. Front Mol Neurosci (2016) 0.75
Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol (2017) 0.75
Modelling FUS Mislocalisation in an In Vitro Model of Innervated Human Muscle. J Mol Neurosci (2017) 0.75
ALS skeletal muscle shows enhanced TGF-β signaling, fibrosis and induction of fibro/adipogenic progenitor markers. PLoS One (2017) 0.75
Onset and progression in inherited ALS determined by motor neurons and microglia. Science (2006) 9.42
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell (1998) 8.10
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet (1997) 7.15
Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci (2004) 6.99
Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A (1997) 6.72
From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci (2001) 6.48
Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A (2001) 6.38
Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science (2003) 6.35
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol (2004) 6.26
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol (2002) 5.82
Functional improvement of dystrophic muscle by myostatin blockade. Nature (2002) 5.10
Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res (1997) 4.74
Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol (2004) 4.69
Gene therapy vectors based on adeno-associated virus type 1. J Virol (1999) 4.63
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science (2003) 4.52
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet (1997) 4.26
Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci (2006) 3.56
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem (2000) 3.46
Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther (2000) 3.32
Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol (2003) 3.25
Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol (2002) 3.03
The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem (2002) 3.01
Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci (2001) 2.85
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol (2005) 2.61
Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet (2001) 2.36
Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve (2005) 2.23
Premorbid weight, body mass, and varsity athletics in ALS. Neurology (2002) 2.23
Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol (2004) 2.12
Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci (2001) 1.99
Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A (2005) 1.81
Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science (1995) 1.70
Targeted retrograde gene delivery for neuronal protection. Mol Ther (2002) 1.59
Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord (2003) 1.55
Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Ann Neurol (2005) 1.44
The number of nuclei in adult rat muscles with special reference to satellite cells. Anat Rec (1977) 1.38
Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol (2005) 1.36
Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol (2003) 1.29
The new frontier in muscular dystrophy research: booster genes. FASEB J (2003) 1.29
Influence of training and of inactivity on muscle strength. Arch Phys Med Rehabil (1970) 1.24
The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci (2001) 1.14
Myostatin inhibition slows muscle atrophy in rodent models of amyotrophic lateral sclerosis. Neurobiol Dis (2006) 1.12
Endurance exercise modulates neuromuscular junction of C57BL/6NNia aging mice. J Appl Physiol (1985) (1997) 1.11
Muscle regeneration through myostatin inhibition. Curr Opin Rheumatol (2005) 1.11
Myostatin, a negative regulator of muscle mass: implications for muscle degenerative diseases. Curr Opin Pharmacol (2005) 1.05
Target-derived cardiotrophin-1 and insulin-like growth factor-I promote neurite growth and survival of developing oculomotor neurons. Mol Cell Neurosci (2002) 0.97
Effect of exercise on the motor unit. Muscle Nerve (1986) 0.97
Can amyotrophic lateral sclerosis patients with respiratory insufficiency exercise? J Neurol Sci (1999) 0.93
Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system. Ann N Y Acad Sci (1993) 0.93
Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia. J Clin Invest (2005) 0.91
Results of resistance exercise on a patient with amyotrophic lateral sclerosis. A case report. Phys Ther (1983) 0.87
Exercise in neuromuscular disease. J Clin Neuromuscul Dis (2003) 0.86
Recombinant growth hormone treatment of amyotrophic lateral sclerosis. Muscle Nerve (1993) 0.84
Mechanisms and functional implications of adult neurogenesis. Cell (2008) 14.50
Functional neurogenesis in the adult hippocampus. Nature (2002) 11.17
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell (2009) 11.10
Onset and progression in inherited ALS determined by motor neurons and microglia. Science (2006) 9.42
New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci (2010) 8.09
ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron (2006) 7.82
Mechanisms underlying inflammation in neurodegeneration. Cell (2010) 7.66
On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer (2005) 7.53
A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell (2010) 7.51
Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41
Exercise enhances learning and hippocampal neurogenesis in aged mice. J Neurosci (2005) 7.14
Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci (2004) 6.99
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature (2005) 6.95
The human CENP-A centromeric nucleosome-associated complex. Nat Cell Biol (2006) 6.85
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol (2008) 6.82
Wnt signalling regulates adult hippocampal neurogenesis. Nature (2005) 6.66
Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus. J Neurosci (2006) 6.48
Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol (2009) 6.43
Astroglia induce neurogenesis from adult neural stem cells. Nature (2002) 6.41
Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell (2006) 6.37
An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat Struct Mol Biol (2009) 6.37
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci (2011) 6.01
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci (2008) 5.89
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet (2010) 5.75
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol (2009) 5.65
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature (2012) 5.47
In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus. Cell Stem Cell (2007) 5.32
An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A (2007) 5.30
L1 retrotransposition in human neural progenitor cells. Nature (2009) 4.78
Rethinking ALS: the FUS about TDP-43. Cell (2009) 4.71
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol (2010) 4.62
Propagation of centromeric chromatin requires exit from mitosis. J Cell Biol (2007) 4.60
A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell (2009) 4.60
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science (2003) 4.52
Therapeutic interventions after spinal cord injury. Nat Rev Neurosci (2006) 4.51
Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice. Development (2003) 4.49
Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron (2012) 4.48
A standardized kinesin nomenclature. J Cell Biol (2004) 4.43
In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A (2011) 4.38
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A (2002) 4.37
Structural determinants for generating centromeric chromatin. Nature (2004) 4.25
Centromere-specific assembly of CENP-a nucleosomes is mediated by HJURP. Cell (2009) 4.22
A role for adult TLX-positive neural stem cells in learning and behaviour. Nature (2008) 4.14
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat Biotechnol (2006) 4.12
Experience-specific functional modification of the dentate gyrus through adult neurogenesis: a critical period during an immature stage. J Neurosci (2007) 4.04
Neurons born in the adult dentate gyrus form functional synapses with target cells. Nat Neurosci (2008) 4.01
NMDA-receptor-mediated, cell-specific integration of new neurons in adult dentate gyrus. Nature (2006) 4.01
Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci (2003) 3.98
Does aneuploidy cause cancer? Curr Opin Cell Biol (2006) 3.89
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci (2008) 3.78
Potential role for adult neurogenesis in the encoding of time in new memories. Nat Neurosci (2006) 3.78
Neuroplasticity in old age: sustained fivefold induction of hippocampal neurogenesis by long-term environmental enrichment. Ann Neurol (2002) 3.76
Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell (2005) 3.69
Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc Natl Acad Sci U S A (2004) 3.69
Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencing. Curr Biol (2004) 3.65
Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron (2013) 3.63
Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A (2004) 3.60
Mosaic copy number variation in human neurons. Science (2013) 3.57
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A (2005) 3.56
Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat Neurosci (2009) 3.47
Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol (2011) 3.45
Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci (2006) 3.41
Adult-born hippocampal dentate granule cells undergoing maturation modulate learning and memory in the brain. J Neurosci (2009) 3.37
Unattached kinetochores catalyze production of an anaphase inhibitor that requires a Mad2 template to prime Cdc20 for BubR1 binding. Dev Cell (2009) 3.36
Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell (2008) 3.34
Synapse formation on neurons born in the adult hippocampus. Nat Neurosci (2007) 3.33
Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron (2002) 3.31
BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature (2011) 3.30
Expression and function of orphan nuclear receptor TLX in adult neural stem cells. Nature (2004) 3.25
L1 retrotransposition in neurons is modulated by MeCP2. Nature (2010) 3.25
Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats. Learn Mem (2009) 3.23
Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E. Dev Cell (2002) 3.23
A functional study of miR-124 in the developing neural tube. Genes Dev (2007) 3.21
A role for glia in the progression of Rett's syndrome. Nature (2011) 3.18
Functional convergence of neurons generated in the developing and adult hippocampus. PLoS Biol (2006) 3.16
YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev (2008) 3.16
Centromere-associated protein-E is essential for the mammalian mitotic checkpoint to prevent aneuploidy due to single chromosome loss. J Cell Biol (2003) 3.15
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest (2012) 3.14
Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat Neurosci (2002) 3.10
Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat Neurosci (2002) 3.09
Neocortical neurogenesis in humans is restricted to development. Proc Natl Acad Sci U S A (2006) 3.08
Development of a novel mouse glioma model using lentiviral vectors. Nat Med (2009) 3.08
Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One (2009) 3.07
Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci (2007) 3.02
Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest (2006) 3.00
A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell (2004) 2.95
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A (2013) 2.95
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol (2008) 2.95
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron (2004) 2.94
Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol (2004) 2.94
Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci (2003) 2.93
Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci (2012) 2.93
Local generation of glia is a major astrocyte source in postnatal cortex. Nature (2012) 2.87
Resolving new memories: a critical look at the dentate gyrus, adult neurogenesis, and pattern separation. Neuron (2011) 2.84
Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell (2012) 2.83
Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J Neurosci (2004) 2.80